25-hydroxyprotopanaxadiol has been researched along with sapogenins in 2 studies
| Studies (25-hydroxyprotopanaxadiol) | Trials (25-hydroxyprotopanaxadiol) | Recent Studies (post-2010) (25-hydroxyprotopanaxadiol) | Studies (sapogenins) | Trials (sapogenins) | Recent Studies (post-2010) (sapogenins) |
|---|---|---|---|---|---|
| 21 | 0 | 19 | 987 | 8 | 443 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, S; Shi, CH; Suo, H; Tang, X; Yang, L; Zhang, X; Zhao, Y | 1 |
| Guo, S; Su, G; Wang, X; Zhang, X; Zhao, C; Zhao, Y | 1 |
2 other study(ies) available for 25-hydroxyprotopanaxadiol and sapogenins
| Article | Year |
|---|---|
Self-microemulsifying drug-delivery system for improved oral bioavailability of 20(S)-25-methoxyl-dammarane-3β, 12β, 20-triol: preparation and evaluation.
Topics: Administration, Oral; Animals; Biological Availability; Chemistry, Pharmaceutical; Drug Delivery Systems; Drug Stability; Emulsions; Female; Ginsenosides; Male; Nanomedicine; Rats; Rats, Wistar; Sapogenins; Solubility; Surface-Active Agents | 2014 |
Antitumor activity of ginseng sapogenins, 25-OH-PPD and 25-OCH3-PPD, on gastric cancer cells.
Topics: Antineoplastic Agents; Caspases; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Damage; Ginsenosides; Humans; Panax; Sapogenins; Signal Transduction; Stomach Neoplasms | 2016 |